Bud BilanichSuccess Coach
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Oxford BioMedica notes that Axovant doses first patient in clinical study of AXO-Lenti-PD, a ...
- Landmark AdVance Study Demonstrates Strong Correlation Between Adenovirus Burden and Mortality Risk - - ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email